InsidersTradesSigma
Track the 佰仁医疗 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 佰仁医疗 has published 18 insider filings. Market capitalisation: €11bn. The latest transaction was disclosed on 2 January 2025 (Purchase). Among the most active insiders: 吴嘉. Every trade is free.
18
Insider Decl.
n/a
Thresholds
€901,932
6 ops.
Buy Volume
€290,659
12 ops.
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,762 of 29,062 companies
58.0
score / 100
Value30
Quality86
FCF yld0.6%
Earn yld1.8%
EV/EBITDA44.3x
ROE15%
Gross mgn89%
Net mgn31%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 January 2025
Declarations18 total
18 of 18 declarations
About 佰仁医疗
佰仁医疗 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical solutions.